" in the absence of patent protection innovation dies."? Sadly, only Judge Newman and Moore recognize that. Amarin is not BP but is still a greedy pharma company, just ask Judge Du, Prost, Huges ...
Great point! It needs to be brought out that this company has bootstrapped this drug from inception, and it is their only drug - not just one drug in a massive portfolio. They alone developed it and paid for all the trials.
Market Data 
Markets 
AI
